vs

Side-by-side financial comparison of 908 Devices Inc. (MASS) and FiscalNote Holdings, Inc. (NOTE). Click either name above to swap in a different company.

FiscalNote Holdings, Inc. is the larger business by last-quarter revenue ($22.2M vs $17.4M, roughly 1.3× 908 Devices Inc.). On growth, 908 Devices Inc. posted the faster year-over-year revenue change (21.2% vs -24.7%). 908 Devices Inc. produced more free cash flow last quarter ($1.3M vs $-1.9M). Over the past eight quarters, 908 Devices Inc.'s revenue compounded faster (53.0% CAGR vs -16.8%).

908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.

FiscalNote Holdings, Inc., or commonly FiscalNote, is a publicly traded software, data, and media company headquartered in Washington, D.C. The company was founded by Timothy Hwang, Gerald Yao, and Jonathan Chen in 2013. FiscalNote provides software tools, platforms, data services, and news through the FiscalNote Government Relationship Management (GRM) service, its core product. The company also uses an artificial intelligence platform to analyze proposed U.S. legislation based on key phrase...

MASS vs NOTE — Head-to-Head

Bigger by revenue
NOTE
NOTE
1.3× larger
NOTE
$22.2M
$17.4M
MASS
Growing faster (revenue YoY)
MASS
MASS
+45.8% gap
MASS
21.2%
-24.7%
NOTE
More free cash flow
MASS
MASS
$3.2M more FCF
MASS
$1.3M
$-1.9M
NOTE
Faster 2-yr revenue CAGR
MASS
MASS
Annualised
MASS
53.0%
-16.8%
NOTE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MASS
MASS
NOTE
NOTE
Revenue
$17.4M
$22.2M
Net Profit
$4.2M
Gross Margin
52.7%
Operating Margin
17.8%
-83.7%
Net Margin
24.0%
Revenue YoY
21.2%
-24.7%
Net Profit YoY
121.5%
EPS (diluted)
$0.09
$-2.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MASS
MASS
NOTE
NOTE
Q4 25
$17.4M
$22.2M
Q3 25
$14.0M
$22.4M
Q2 25
$13.0M
$23.3M
Q1 25
$11.8M
$27.5M
Q4 24
$14.3M
$29.5M
Q3 24
$14.5M
$29.4M
Q2 24
$11.5M
$29.2M
Q1 24
$7.4M
$32.1M
Net Profit
MASS
MASS
NOTE
NOTE
Q4 25
$4.2M
Q3 25
$-15.0M
$-24.9M
Q2 25
$-13.3M
$-13.3M
Q1 25
$43.6M
$-4.3M
Q4 24
$-19.4M
Q3 24
$-29.3M
$-14.9M
Q2 24
$-12.5M
$-12.8M
Q1 24
$-10.9M
$50.6M
Gross Margin
MASS
MASS
NOTE
NOTE
Q4 25
52.7%
Q3 25
52.5%
Q2 25
48.9%
Q1 25
47.0%
Q4 24
46.5%
Q3 24
53.6%
Q2 24
53.8%
Q1 24
52.4%
Operating Margin
MASS
MASS
NOTE
NOTE
Q4 25
17.8%
-83.7%
Q3 25
-116.6%
-43.4%
Q2 25
-116.3%
-31.9%
Q1 25
-93.6%
-50.0%
Q4 24
-116.8%
-19.4%
Q3 24
-168.7%
-23.1%
Q2 24
-74.5%
-27.2%
Q1 24
-102.5%
-35.6%
Net Margin
MASS
MASS
NOTE
NOTE
Q4 25
24.0%
Q3 25
-107.0%
-110.8%
Q2 25
-102.1%
-57.0%
Q1 25
370.2%
-15.4%
Q4 24
-135.6%
Q3 24
-201.8%
-50.7%
Q2 24
-109.5%
-43.6%
Q1 24
-147.1%
157.6%
EPS (diluted)
MASS
MASS
NOTE
NOTE
Q4 25
$0.09
$-2.81
Q3 25
$-0.41
$-1.73
Q2 25
$-0.37
$-0.08
Q1 25
$1.23
$-0.03
Q4 24
$-0.58
$1.88
Q3 24
$-0.84
$-1.33
Q2 24
$-0.37
$-0.09
Q1 24
$-0.33
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MASS
MASS
NOTE
NOTE
Cash + ST InvestmentsLiquidity on hand
$113.0M
$26.3M
Total DebtLower is stronger
$128.4M
Stockholders' EquityBook value
$143.7M
$62.0M
Total Assets
$190.1M
$255.1M
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MASS
MASS
NOTE
NOTE
Q4 25
$113.0M
$26.3M
Q3 25
$112.1M
$31.2M
Q2 25
$118.6M
$38.5M
Q1 25
$124.3M
$46.3M
Q4 24
$69.6M
$34.6M
Q3 24
$71.7M
$32.7M
Q2 24
$77.4M
$37.7M
Q1 24
$134.2M
$43.6M
Total Debt
MASS
MASS
NOTE
NOTE
Q4 25
$128.4M
Q3 25
$131.5M
Q2 25
$116.7M
Q1 25
$118.0M
Q4 24
$147.1M
Q3 24
$152.2M
Q2 24
$145.9M
Q1 24
$153.0M
Stockholders' Equity
MASS
MASS
NOTE
NOTE
Q4 25
$143.7M
$62.0M
Q3 25
$136.3M
$75.5M
Q2 25
$148.8M
$95.1M
Q1 25
$159.4M
$98.7M
Q4 24
$114.6M
$97.8M
Q3 24
$131.0M
$98.5M
Q2 24
$156.4M
$106.9M
Q1 24
$156.9M
$106.1M
Total Assets
MASS
MASS
NOTE
NOTE
Q4 25
$190.1M
$255.1M
Q3 25
$190.9M
$273.9M
Q2 25
$191.7M
$288.3M
Q1 25
$196.0M
$299.7M
Q4 24
$159.5M
$326.2M
Q3 24
$178.3M
$337.9M
Q2 24
$208.8M
$346.3M
Q1 24
$189.8M
$357.8M
Debt / Equity
MASS
MASS
NOTE
NOTE
Q4 25
2.07×
Q3 25
1.74×
Q2 25
1.23×
Q1 25
1.20×
Q4 24
1.50×
Q3 24
1.54×
Q2 24
1.36×
Q1 24
1.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MASS
MASS
NOTE
NOTE
Operating Cash FlowLast quarter
$1.3M
$-279.0K
Free Cash FlowOCF − Capex
$1.3M
$-1.9M
FCF MarginFCF / Revenue
7.6%
-8.7%
Capex IntensityCapex / Revenue
0.0%
7.4%
Cash ConversionOCF / Net Profit
0.32×
TTM Free Cash FlowTrailing 4 quarters
$-24.7M
$-18.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MASS
MASS
NOTE
NOTE
Q4 25
$1.3M
$-279.0K
Q3 25
$-4.2M
$-8.3M
Q2 25
$-5.8M
$-6.2M
Q1 25
$-15.0M
$3.3M
Q4 24
$-2.2M
$-1.3M
Q3 24
$-5.6M
$-3.0M
Q2 24
$-13.0M
$-3.7M
Q1 24
$-9.4M
$2.7M
Free Cash Flow
MASS
MASS
NOTE
NOTE
Q4 25
$1.3M
$-1.9M
Q3 25
$-4.9M
$-10.4M
Q2 25
$-5.9M
$-7.7M
Q1 25
$-15.2M
$1.3M
Q4 24
$-2.4M
$-3.4M
Q3 24
$-5.8M
$-5.4M
Q2 24
$-13.7M
$-6.5M
Q1 24
$-10.3M
$1.0M
FCF Margin
MASS
MASS
NOTE
NOTE
Q4 25
7.6%
-8.7%
Q3 25
-34.9%
-46.2%
Q2 25
-45.3%
-33.0%
Q1 25
-128.9%
4.7%
Q4 24
-17.0%
-11.4%
Q3 24
-39.7%
-18.4%
Q2 24
-119.4%
-22.1%
Q1 24
-138.2%
3.3%
Capex Intensity
MASS
MASS
NOTE
NOTE
Q4 25
0.0%
7.4%
Q3 25
4.9%
9.3%
Q2 25
0.9%
6.4%
Q1 25
1.4%
7.2%
Q4 24
1.3%
6.8%
Q3 24
1.1%
8.3%
Q2 24
5.6%
9.4%
Q1 24
12.2%
5.3%
Cash Conversion
MASS
MASS
NOTE
NOTE
Q4 25
0.32×
Q3 25
Q2 25
Q1 25
-0.34×
Q4 24
Q3 24
Q2 24
Q1 24
0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MASS
MASS

Products$14.3M82%
Services$3.0M18%

NOTE
NOTE

Subscription$21.2M95%
Advisory Advertising And Other$1.0M5%

Related Comparisons